Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
13,125.00
0.00
(0.00%)
At close: February 28 at 4:59:07 PM GMT-3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 24 | 23 | 30 | 30 |
| Avg. Estimate | 2.25B | 2.32B | 9.17B | 9.18B |
| Low Estimate | 2.16B | 2.27B | 8.97B | 8.6B |
| High Estimate | 2.42B | 2.46B | 9.5B | 10.14B |
| Year Ago Sales | 2.29B | 2.46B | 9.68B | 9.17B |
| Sales Growth (year/est) | -1.89% | -5.69% | -5.21% | 0.12% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BIIB.BA | -- | -- | -- | -- |
| S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Related Tickers
AMGN.MX Amgen Inc.
6,032.00
0.00%
AMGN.BA Amgen Inc.
12,500.00
+0.81%
PFEB.F Pfizer Inc.
7.75
-1.27%
MRK.BA Merck & Co., Inc.
22,375.00
+1.94%
PFE.BA Pfizer Inc.
7,990.00
-0.12%
GSK.L GSK plc
1,466.50
+0.38%
GSK GSK plc
37.59
+0.78%
AMGN Amgen Inc.
308.06
+0.73%
GILD Gilead Sciences, Inc.
114.31
+2.07%
BMY Bristol-Myers Squibb Company
59.62
+1.39%